✦ LIBER ✦

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis

✍ Scribed by Val Gebski; Bryan Burmeister; B Mark Smithers; Kerwyn Foo; John Zalcberg; John Simes

Book ID: 117784229
Publisher: The Lancet
Year: 2007
Tongue: English
Weight: 188 KB
Volume: 8
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(07)70039-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Survival after neoadjuvant chemotherapy

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis

✍ Katrin M Sjoquist; Bryan H Burmeister; B Mark Smithers; John R Zalcberg; R John 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 392 KB

Neoadjuvant Chemoradiotherapy Could Impr

Neoadjuvant Chemoradiotherapy Could Improve Survival Outcomes for Esophageal Carcinoma: A Meta-Analysis

✍ Dong-Bin Wang, Xun Zhang, Hong-Li Han, Yi-Jun Xu, Da-Qiang Sun, Zhen-Liang Shi 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 451 KB

Survival Benefits from Preoperative Radi

Survival Benefits from Preoperative Radiation Therapy in Gastric Carcinoma: A Meta-analysis

✍ J.J. Lu; T. Liu; C. Leong; J. Tey; Z. Zhang 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Survival benefit of chemotherapy in meta

Survival benefit of chemotherapy in metastatic colorectal cancer: a meta-analysis of randomized controlled trials

✍ Jonker, D J; Maroun, J A; Kocha, W 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 66 KB

Neoadjuvant Chemotherapy or Primary Debu

Neoadjuvant Chemotherapy or Primary Debulking Surgery in Advanced Ovarian Carcinoma: A Retrospective Analysis of 285 Patients

✍ I. Vergote; I. De Wever; W. Tjalma; M. Van Gramberen; J. Decloedt; P. van Dam 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Pharmacoproteomic analysis of prechemoth

Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma

✍ Lajos Pusztai; Betsy W. Gregory; Keith A. Baggerly; Bo Peng; John Koomen; Henry 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 303 KB

## Abstract ## BACKGROUND In this study, proteomic changes were examined in response to paclitaxel chemotherapy or 5‐fluorouracil, doxorubicin, and cyclophosphamide (FAC) chemotherapy in plasma from patients with Stage I–III breast carcinoma. The authors also compared the plasma profiles of patien